Rot fluoreszierende saRNA Deutschland

• A New Tool in Gene Therapy

  Gene therapy is the burgeoning field, similar to the Yaohai's product like E. coli-Fermentation zur VLP-Produktion. Then daily it is creating even more new techniques and tools so that there is a way, for us to showcase better behavior against diseases. One such new tool is the Red Fluorescent saRNA. This will enable the researchers to track where in the body helpful RNA goes and how it could support a cell that lacks it. This is a good trait because it allows doctors to more usefully direct treatments at cut diseases, like cancer. 

• Advancing Gene Therapy with Red Fluorescent saRNA

  In addition to the desirable properties of a red fluorescent saRNA, this work can provide yet another piece of information about how RNA novelty uses in our bodies, also the Herstellung von mRNA-Plasmiden built by Yaohai. With these colorful tints, scientists can pass the RNA to some cells and see how that may help in treatment. It might yield novel approaches for treating a broad spectrum of diseases. For example, this type of AI could shed a light on the RNA- Cell interactions which then lead to personalised medications.

• From the Labs to the Future - The Rise of Red Fluorescent saRNA

  Red fluorescent saRNA is still being tested in the laboratory, but previous results on animal models are very good, similar to the Yaohai's product like Rot fluoreszierende mRNA. Scientists all over the world are researching in depth to use this technology in healthcare and moving towards new aspects including drug delivery. But as this technology improves, I suspect we will use AI broadly in health care over time. This may be tracking and treating diseases down to a pinpoint, but could also mean creating new vaccines to prevent diseases.

Why choose Yaohai Red Fluorescent saRNA?

• Anpassung, Effizienz und Kosteneffizienz

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as Red Fluorescent saRNA of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Fachkompetenz und langjährige Erfahrung

  Yaohai Bio-Pharma is a leading microbiological CDMO. Our focus has been on microbially produced Red Fluorescent saRNA and vaccines for human, veterinary and the management of pet health. We have state-of-the-art RD platforms and manufacturing methods which cover the entire procedure starting with microbial strain creation and cell banking, to process and method development to commercial and clinical production and implementation of cutting-edge solutions. Over the years we have gained vast expertise in bio processing using microbial sources. We have successfully delivered over 200 projects across the globe and have assisted our clients with navigating the regulations from the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react rapidly to market requirements and offer a customized CDMO services due to our expertise and knowledge.

• Qualitätssystem und Einhaltung globaler Vorschriften

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and Red Fluorescent saRNA. We have developed a solid quality system that adheres to current GMP standards and regulatory requirements worldwide. Our regulatory team is knowledgeable on global regulatory frameworks to expedite biological launches. We make sure that production processes are traceable with high-quality products as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also in compliance. Yaohai BioPharma successfully passed an on-site audit conducted by a Qualified Person from the European Union (QP) to examine our GMP process and manufacturing facility. We also successfully been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Robuste Lieferkette und Fertigungskapazitäten

  Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have built a modern facility with robust RD capabilities and advanced equipment. We have five drug substance manufacturing lines that conform to GMP requirements for microbial fermentation and purification. We also have two automated fill-finish lines for cartridges, vials and pre-filled syringes. The fermentation scales available for use range from Red Fluorescent saRNA to 2000L. The specifications for the filling of a vial range from 1ml up to 25ml. pre-filled syringe or cartridge filling specifications range from approximately 1-3ml. Our cGMP-compliant production facility ensures constant supply of clinical sample as well as commercial items. Our plant produces big molecules which are shipped to the globe.

Verwandte Produktkategorien

• AAV-Plasmidherstellung
• Analytische Methoden für Plasmid-DNA
• Herstellung des Bakteriophagen AP205 VLP
• Herstellung von Bakteriophage Q VLP
• Herstellung chimärer VLP-Impfstoffe
• Herstellung konjugierter VLP-Impfstoffe
• Herstellung von DNA-Impfstoffen
• E. coli-Fermentation zur VLP-Produktion
• Herstellung von GLP-1-Agonisten
• GLP-1 Analoge Fertigung

Finden Sie nicht, was Sie suchen?
Kontaktieren Sie unsere Berater für weitere verfügbare Produkte.